Chevy Chase Trust’s iShares Biotechnology ETF IBB Stock Holding History

Chevy Chase Trust’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-5,145	Closed	-$785K	–	656
2021 Q4	$785K	Buy	+5,145	New	+$797K	﹤0.01%	590
2020 Q1	–	Sell	-550	Closed	-$66K	–	795
2019 Q4	$66K	Buy	+550	New	+$61.4K	﹤0.01%	779
2019 Q1	–	Sell	-450	Closed	-$43K	–	674
2018 Q4	$43K	Buy	+450	New	+$47.8K	﹤0.01%	694
2017 Q1	–	Sell	-6,030	Closed	-$533K	–	660
2016 Q4	$533K	Buy	+6,030	New	+$549K	﹤0.01%	583

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Chevy Chase Trust's IBB Position: Q1 2022 in Review

Chevy Chase Trust sold out of iShares Biotechnology ETF (IBB) in Q1 2022, closing a stake of 5,145 shares — an estimated $785K sold.

Chevy Chase Trust first reported a position in IBB in Q4 2016 and held it in 4 quarters. The position peaked at $785K in Q4 2021. 897 funds tracked by Wall St. Rank hold IBB as of Q1 2022.

Chevy Chase Trust reported no remaining iShares Biotechnology ETF position as of Q1 2022 after selling out during the quarter.
Chevy Chase Trust sold 5,145 iShares Biotechnology ETF shares in Q1 2022, an estimated $785K.
Chevy Chase Trust first reported a position in iShares Biotechnology ETF in Q4 2016 and held it in 4 quarters.
Chevy Chase Trust's iShares Biotechnology ETF position peaked at $785K in Q4 2021.
897 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2022.

Based on Chevy Chase Trust's 13F filing for Q1 2022, filed 27 Apr 2022.